Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of an Artificial-pancreas-like Learning-based Control in Type 1 Diabetes on Multiple Daily Injection Therapy: Protocol of a Multi-center, Non-inferiority, Randomized Controlled Trial (ELITE Study)
Conditions
Interventions
AP-A Dosage Decision Support System
Start Date
July 1, 2024
Primary Completion Date
March 30, 2025
Completion Date
June 30, 2025
Last Updated
May 17, 2024
NCT04786262
NCT06748963
NCT06325202
NCT07305805
NCT07292558
NCT05180591
Lead Sponsor
Peking University People's Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions